ClinicalTrials.gg
CompletedNCT04354168Updated Sep 18, 2023Results posted

Nthabi in Lesotho - Implementation

An interventional study of mHealth Application in Preconception Care, sponsored by Boston University. Completed at 1 site in Lesotho. Open to female participants aged 18 Years to 28 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-09-18.

Sponsored by Boston University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Not applicable
Ages
18 Years to 28 Years
Sex
Female
01

Study summary

This project will determine how well the mobile health (mHealth) Nthabi application is introduced and used at district hospitals in Lesotho. This will help with measuring the effectiveness of an evidence-based mHealth application in a low-income country. Three factors will be studied when assessing the mHealth application's overall impact: 1) end-user content knowledge 2) pre and post stage of change and 3) system usage. This data will be collected by the mHealth application. End-users will use the mHealth application over a period of two months. Results will be shared with the clinical, health services research, information technology, and policy communities.

Read the detailed description

Lesotho has second-highest HIV and fifth-highest tuberculosis prevalence rates worldwide, and a maternal mortality rate (1024/100,000) that is among the highest in Africa. As there are only 6.2 nurses and 0.5 physicians per 10,000 people, both about one-third of the African average, there is an enormous need for eHealth systems to assist the clinical care system.

Preconception care is an effort to focus on engaging young women in their health before they become pregnant since many women enter pregnancy at risk for poor outcomes because of preexisting medical conditions or not following evidence-based preventive action. In 2013, the WHO prioritized research that focuses on developing, delivering, and scaling preconception women's health interventions in low and middle-income countries to optimize health and birth outcomes. The WHO emphasized implementation research as the key step in helping to maximize the coverage and uptake of preconception care to enhance the long-term health outcomes for women and their children.

The existing "Gabby" system is a patient-facing, user-friendly, evidence-based, scalable, culturally adaptive, health communication system designed to improve women's health. The investigator's team has developed and tested several Embodied Conversational Agents (ECAs), which are virtual characters designed using expertise from health communication, psychotherapy, social psychology, sociolinguistics, linguistics, and communication theory.

For this project, the investigators will first adapt the existing "Gabby" system to a culturally appropriate mHealth application, called "Nthabi", and second, study the impact of the Nthabi application into district hospitals in Lesotho in partnership with the Lesotho Boston Health Alliance (LeBoHA) using the existing educational infrastructure. The research team will assess the effectiveness of Nthabi based on the periodic stage of change assessments over the two-month implementation, end-user content knowledge, and system usage.

02

Conditions studied

  • Preconception Care

Keywords

  • mHealth
  • Lesotho
03

In context

Lead sponsor

Boston University is the lead sponsor of 270 studies on the registry; 36 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 24 (77%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 28 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female Resident of Lesotho
  • English Speaking
  • Have access to an Android smartphone
  • Not currently pregnant at time of enrollment

Exclusion criteria

Exclusion Criteria:

-None

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
160 participants (actual)

Study arms

  • Experimental
    Nthabi mHealth Application

    About 20 women from each of the ten district hospitals will be recruited. Each district hospital will have a separate administrative page on the Nthabi server where women will be enrolled with a unique username and password. Upon enrollment, the women will be asked to engage with Nthabi for two months to discuss the relevant content areas they are interested in learning more about.

    Behavioral: mHealth Application

Interventions

  • BehavioralmHealth Application

    Nthabi mHealth Application delivers educational content and recommendations to minimize or eliminate health risks. The content is delivered via the Nthabi application downloaded on an Android phone smartphone. End-users can select from a list of topics relevant to the Lesotho population to engage with the conversational agent, Nthabi, and discuss conditions such as tuberculosis, HIV testing, healthy diet, and family planning.

06

What researchers measure

Primary outcomes

  1. Change in Preconception Health Knowledge

    Change in preconception health knowledge will be assessed by a change in the percentage correct scores between the Pre and Post tests which were developed by the investigator. Higher positive change scores suggest more knowledge about preconception health.

    Time frame: Baseline, 4 weeks

Secondary outcomes

  1. Ease of Use of Nthabi App

    This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

    Time frame: 4 weeks

  2. Nthabi App Health Education Content Organized and Timely

    This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

    Time frame: 4 weeks

  3. Able to Complete Tasks Quickly Using Nthabi

    This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

    Time frame: 4 weeks

  4. Enjoyed Using the Nthabi App

    This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

    Time frame: 4 weeks

  5. Intend to Keep Using the Nthabi App

    This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

    Time frame: 4 weeks

  6. The Nthabi App Was Culturally Appropriate

    This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

    Time frame: 4 weeks

07

Results

Posted Sep 18, 2023

Participant flow

Participant flow — Overall Study
MilestoneNthabi mHealth Application
Started160
Completed138
Not completed22
Withdrew: Lost to follow-up22

Outcome measures

PrimaryChange in Preconception Health Knowledge

Change in preconception health knowledge will be assessed by a change in the percentage correct scores between the Pre and Post tests which were developed by the investigator. Higher positive change scores suggest more knowledge about preconception health.

Time frame:
Baseline, 4 weeks
Reported as:
Number · percentage change pre to post test
Change in Preconception Health Knowledge
percentage change pre to post testNthabi mHealth Application
Folic acid knowledge58.1
Family planning knowledge14.8
Healthy eating knowledge4.3
SecondaryEase of Use of Nthabi App

This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

Time frame:
4 weeks
Reported as:
Number · percentage strongly agree or agree
Ease of Use of Nthabi App
percentage strongly agree or agreeNthabi mHealth Application
Ease of Use of Nthabi App98.6
SecondaryNthabi App Health Education Content Organized and Timely

This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

Time frame:
4 weeks
Reported as:
Number · percentage strongly agree or agree
Nthabi App Health Education Content Organized and Timely
percentage strongly agree or agreeNthabi mHealth Application
Nthabi App Health Education Content Organized and Timely95.7
SecondaryAble to Complete Tasks Quickly Using Nthabi

This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

Time frame:
4 weeks
Reported as:
Number · percentage strongly agree or agree
Able to Complete Tasks Quickly Using Nthabi
percentage strongly agree or agreeNthabi mHealth Application
Able to Complete Tasks Quickly Using Nthabi95.7
SecondaryEnjoyed Using the Nthabi App

This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

Time frame:
4 weeks
Reported as:
Number · percentage strongly agree or agree
Enjoyed Using the Nthabi App
percentage strongly agree or agreeNthabi mHealth Application
Enjoyed Using the Nthabi App96.4
SecondaryIntend to Keep Using the Nthabi App

This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

Time frame:
4 weeks
Reported as:
Number · percentage strongly agree or agree
Intend to Keep Using the Nthabi App
percentage strongly agree or agreeNthabi mHealth Application
Intend to Keep Using the Nthabi App92.1
SecondaryThe Nthabi App Was Culturally Appropriate

This outcome was assessed by responses to a specific question in an investigator developed survey containing 22 questions eliciting responses on a 4-point Likert scale (strongly agree, agree, disagree, and strongly disagree). The higher the percentage of strongly agree or agree responses the more favorable the results.

Time frame:
4 weeks
Reported as:
Number · percentage strongly agree or agree
The Nthabi App Was Culturally Appropriate
percentage strongly agree or agreeNthabi mHealth Application
The Nthabi App Was Culturally Appropriate96.4

Adverse events

Collected over 6 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Nthabi mHealth Application0/138 (0%)0/138 (0%)0/138 (0%)

Baseline characteristics

Age, Customized
Age, Customized(Participants)Nthabi mHealth Application
18-2034
21-2353
24-2637
27-2814
Sex: Female, Male
Sex: Female, Male(Participants)Nthabi mHealth Application
Female138
Male0
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Nthabi mHealth Application
Region of Enrollment
Region of Enrollment(participants)Nthabi mHealth Application
Lesotho138
08

Study locations

1 site
  • Lesotho Boston Health Alliance
    Maseru, 105, Lesotho
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04354168
Lead sponsor
Boston University
Responsible party
Sponsor
First posted
Apr 21, 2020
Start date
Nov 8, 2021
Primary completion
Aug 25, 2022
Completion
Aug 25, 2022
Results posted
Sep 18, 2023
Last update
Sep 18, 2023

Study contacts

Brian Jack, MD
principal investigator · Boston University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion